Vaccines (Sep 2021)

A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine

  • Kana Yamamoto,
  • Takahisa Mashiba,
  • Keisuke Takano,
  • Toshihiko Suzuki,
  • Masahiro Kami,
  • Morihito Takita,
  • Eiji Kusumi,
  • Yasuhiro Mizuno,
  • Tamae Hamaki

DOI
https://doi.org/10.3390/vaccines9101108
Journal volume & issue
Vol. 9, no. 10
p. 1108

Abstract

Read online

COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first dose of COVID-19 vaccination. This case report shows the importance of considering hyperthyroidism as a possible complication after COVID-19 vaccination.

Keywords